Jens Ravens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jens ravens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jens Ravens Today - Breaking & Trending Today

EQS-Adhoc: Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 - adhoc - Börsennachrichten

EQSAdhoc Epigenomics AG Key word Personnel Epigenomics AG Executive Board member Jens Ravens leaves the Company on April 30 2024 30Oct2023 1549 CETCEST Disclosure of an inside information acc to Arti ....

Company To New Day Diagnostics , Board Of The Company , Company On , Executive Board , Jens Ravens , Frankfurt General Standard , New Day Diagnostics , Supervisory Board , Frederic Hilke ,

Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024

Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 202430-Oct-2023 / 15:49 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is so. ....

Company To New Day Diagnostics , Board Of The Company , Distribution Services , Company On , Executive Board , Jens Ravens , Frankfurt General Standard , New Day Diagnostics , Supervisory Board , Frederic Hilke , Regulatory Announcements , Corporate News ,

DGAP-News: Epigenomics AG Reports Financial Results for Fiscal Year 2021

DGAP-News: Epigenomics AG / Key word(s): Annual Report/Annual Results Epigenomics AG Reports Financial Results for Fiscal Year 2021 . ....

San Diego , United States , United Kingdom , Andrew Lukowiak , Greg Hamilton , Company Epi , Centers For Medicare , Drug Administration , Medicaid Services , Financial Results , Fiscal Year , United Statesa , President Biden , Cancer Moonshot , Executive Board , Chief Scientific Officer Andrew Lukowiak , Chief Scientific Officer , Jens Ravens , Annual Report , Frederic Hilke ,